(XHR) Xenia Hotels & Resorts - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9840171030
Stock: Hotels, Resorts, Lodging
Total Rating 41
Risk 56
Buy Signal -0.62
| Risk 5d forecast | |
|---|---|
| Volatility | 32.2% |
| Relative Tail Risk | -9.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -1.62 |
| Character TTM | |
|---|---|
| Beta | 1.162 |
| Beta Downside | 1.738 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.47% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: XHR Xenia Hotels & Resorts March 05, 2026
Xenia Hotels & Resorts, Inc. (XHR) is a self-managed REIT focused on luxury and upper-upscale hotels. REITs (Real Estate Investment Trusts) are companies that own, operate, or finance income-producing real estate.
XHRs portfolio includes 30 properties with 8,868 rooms across 14 U.S. states. The company targets the top 25 lodging markets and key leisure destinations. Its hotels operate under brands such as Marriott, Hyatt, and Hilton, a common practice in the hospitality industry where brand recognition drives bookings.
To deepen your understanding of XHRs operational metrics and competitive landscape, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Luxury hotel demand recovers in key US leisure markets
- Business travel resurgence boosts urban hotel occupancy
- Interest rate hikes increase REIT financing costs
- Labor shortages elevate hotel operating expenses
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 63.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.38 > 1.0 |
| NWC/Revenue: 5.59% < 20% (prev 5.19%; Δ 0.40% < -1%) |
| CFO/TA 0.06 > 3% & CFO 176.5m > Net Income 63.1m |
| Net Debt (1.30b) to EBITDA (240.8m): 5.39 < 3 |
| Current Ratio: 1.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (93.9m) vs 12m ago -7.60% < -2% |
| Gross Margin: 1.47% > 18% (prev 0.24%; Δ 122.3% > 0.5%) |
| Asset Turnover: 38.24% > 50% (prev 36.69%; Δ 1.55% > 0%) |
| Interest Coverage Ratio: 1.28 > 6 (EBITDA TTM 240.8m / Interest Expense TTM 86.0m) |
Altman Z'' -0.81
| A: 0.02 (Total Current Assets 167.4m - Total Current Liabilities 107.1m) / Total Assets 2.81b |
| B: -0.24 (Retained Earnings -670.4m / Total Assets 2.81b) |
| C: 0.04 (EBIT TTM 110.1m / Avg Total Assets 2.82b) |
| D: -0.41 (Book Value of Equity -669.4m / Total Liabilities 1.63b) |
| Altman-Z'' Score: -0.81 = CCC |
Beneish M
| DSRI: 1.01 (Receivables 26.9m/25.8m, Revenue 1.08b/1.04b) |
| GMI: 16.57 (GM 1.47% / 24.28%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.04 (Revenue 1.08b / 1.04b) |
| TATA: -0.04 (NI 63.1m - CFO 176.5m) / TA 2.81b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of XHR shares?
As of March 23, 2026, the stock is trading at USD 14.27 with a total of 1,406,411 shares traded.
Over the past week, the price has changed by +0.78%, over one month by -11.37%, over three months by -2.97% and over the past year by +17.81%.
Over the past week, the price has changed by +0.78%, over one month by -11.37%, over three months by -2.97% and over the past year by +17.81%.
Is XHR a buy, sell or hold?
Xenia Hotels & Resorts has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold XHR.
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the XHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.4 | 14.9% |
| Analysts Target Price | 16.4 | 14.9% |
XHR Fundamental Data Overview March 21, 2026
P/E Trailing = 23.0
P/E Forward = 63.2911
P/S = 1.3735
P/B = 1.196
Revenue TTM = 1.08b USD
EBIT TTM = 110.1m USD
EBITDA TTM = 240.8m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.30b USD (from netDebt column, last quarter)
Enterprise Value = 2.78b USD (1.48b + Debt 1.44b - CCE 140.4m)
Interest Coverage Ratio = 1.28 (Ebit TTM 110.1m / Interest Expense TTM 86.0m)
EV/FCF = 30.91x (Enterprise Value 2.78b / FCF TTM 89.9m)
FCF Yield = 3.24% (FCF TTM 89.9m / Enterprise Value 2.78b)
FCF Margin = 8.34% (FCF TTM 89.9m / Revenue TTM 1.08b)
Net Margin = 5.85% (Net Income TTM 63.1m / Revenue TTM 1.08b)
Gross Margin = 1.47% ((Revenue TTM 1.08b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = -60.45% (prev 5.65%)
Tobins Q-Ratio = 0.99 (Enterprise Value 2.78b / Total Assets 2.81b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.44b)
Taxrate = 2.04% (1.39m / 68.3m)
NOPAT = 107.9m (EBIT 110.1m * (1 - 2.04%))
Current Ratio = 1.56 (Total Current Assets 167.4m / Total Current Liabilities 107.1m)
Debt / Equity = 1.27 (Debt 1.44b / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = 5.39 (Net Debt 1.30b / EBITDA 240.8m)
Debt / FCF = 14.43 (Net Debt 1.30b / FCF TTM 89.9m)
Total Stockholder Equity = 1.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 63.1m / Total Assets 2.81b)
RoE = 5.33% (Net Income TTM 63.1m / Total Stockholder Equity 1.18b)
RoCE = 4.22% (EBIT 110.1m / Capital Employed (Equity 1.18b + L.T.Debt 1.42b))
RoIC = 4.14% (NOPAT 107.9m / Invested Capital 2.61b)
WACC = 5.89% (E(1.48b)/V(2.92b) * Re(10.20%) + D(1.44b)/V(2.92b) * Rd(1.48%) * (1-Tc(0.02)))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.45%
[DCF] Terminal Value 85.21% ; FCFF base≈63.2m ; Y1≈56.9m ; Y5≈48.7m
[DCF] Fair Price = 1.89 (EV 1.47b - Net Debt 1.30b = Equity 174.6m / Shares 92.2m; r=5.90% [WACC]; 5y FCF grow -12.43% → 2.90% )
EPS Correlation: 5.58 | EPS CAGR: 23.76% | SUE: 0.37 | # QB: 0
Revenue Correlation: 28.88 | Revenue CAGR: 6.41% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=0.28 | Chg7d=+0.020 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+2.6%
EPS next Year (2027-12-31): EPS=0.42 | Chg7d=+0.080 | Chg30d=+0.080 | Revisions Net=+0 | Growth EPS=+49.1% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = -1.4% (Analyst 4.4% - Implied 5.9%)
P/E Forward = 63.2911
P/S = 1.3735
P/B = 1.196
Revenue TTM = 1.08b USD
EBIT TTM = 110.1m USD
EBITDA TTM = 240.8m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.30b USD (from netDebt column, last quarter)
Enterprise Value = 2.78b USD (1.48b + Debt 1.44b - CCE 140.4m)
Interest Coverage Ratio = 1.28 (Ebit TTM 110.1m / Interest Expense TTM 86.0m)
EV/FCF = 30.91x (Enterprise Value 2.78b / FCF TTM 89.9m)
FCF Yield = 3.24% (FCF TTM 89.9m / Enterprise Value 2.78b)
FCF Margin = 8.34% (FCF TTM 89.9m / Revenue TTM 1.08b)
Net Margin = 5.85% (Net Income TTM 63.1m / Revenue TTM 1.08b)
Gross Margin = 1.47% ((Revenue TTM 1.08b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = -60.45% (prev 5.65%)
Tobins Q-Ratio = 0.99 (Enterprise Value 2.78b / Total Assets 2.81b)
Interest Expense / Debt = 1.48% (Interest Expense 21.2m / Debt 1.44b)
Taxrate = 2.04% (1.39m / 68.3m)
NOPAT = 107.9m (EBIT 110.1m * (1 - 2.04%))
Current Ratio = 1.56 (Total Current Assets 167.4m / Total Current Liabilities 107.1m)
Debt / Equity = 1.27 (Debt 1.44b / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = 5.39 (Net Debt 1.30b / EBITDA 240.8m)
Debt / FCF = 14.43 (Net Debt 1.30b / FCF TTM 89.9m)
Total Stockholder Equity = 1.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 63.1m / Total Assets 2.81b)
RoE = 5.33% (Net Income TTM 63.1m / Total Stockholder Equity 1.18b)
RoCE = 4.22% (EBIT 110.1m / Capital Employed (Equity 1.18b + L.T.Debt 1.42b))
RoIC = 4.14% (NOPAT 107.9m / Invested Capital 2.61b)
WACC = 5.89% (E(1.48b)/V(2.92b) * Re(10.20%) + D(1.44b)/V(2.92b) * Rd(1.48%) * (1-Tc(0.02)))
Discount Rate = 10.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.45%
[DCF] Terminal Value 85.21% ; FCFF base≈63.2m ; Y1≈56.9m ; Y5≈48.7m
[DCF] Fair Price = 1.89 (EV 1.47b - Net Debt 1.30b = Equity 174.6m / Shares 92.2m; r=5.90% [WACC]; 5y FCF grow -12.43% → 2.90% )
EPS Correlation: 5.58 | EPS CAGR: 23.76% | SUE: 0.37 | # QB: 0
Revenue Correlation: 28.88 | Revenue CAGR: 6.41% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.23 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=0.28 | Chg7d=+0.020 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+2.6%
EPS next Year (2027-12-31): EPS=0.42 | Chg7d=+0.080 | Chg30d=+0.080 | Revisions Net=+0 | Growth EPS=+49.1% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = -1.4% (Analyst 4.4% - Implied 5.9%)